Maze Therapeutics Inc. (MAZE)

followers · Follow

CEO:	Jason Coloma
Employees:	121
Web site:	mazetx.com
171 OYSTER POINT BOULEVARD, SUITE 300, SAN FRANCISCO, CA, 94080 6508505070

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

We are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. Our principal executive offices are located at 171 Oyster Point Blvd., Suite 300, South San Francisco, California.

Please log in first to see chart

Maze Therapeutics Inc. YCharts
Yahoo! Finance	finviz

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available